Related Experiment Video
Updated: Jun 14, 2026
The Generation of Closed Femoral Fractures in Mice: A Model to Study Bone Healing
Published on: August 16, 2018
Distinct functionalities of bone morphogenetic protein antagonists during fracture healing in mice
Daniel B Dean1, John T Watson, Wu Jin
1Department of Orthopaedic Surgery, Saint Louis University, St. Louis, MO 63110, USA.
Abstract:
The bone morphogenetic protein (BMP) family of growth factors plays critical roles in bone formation. BMPs are regulated at multiple levels by various BMP antagonists. This study investigated how BMP antagonists are integrated into the cascade of events of bone formation during fracture healing. Forty mice underwent a controlled femur fracture; tissue samples at the fracture site were harvested at days 1, 3, 7, 14 and 21 after fracture, for quantification of the expression of BMPs and BMP antagonists. During fracture healing, BMP-2, -4 and -7 were up-regulated, but BMPR-1A and BMPR-2 showed reduced expression after day 14. Among BMP antagonists, the expressions of PRDC, SOST, Smad7, GREM1 and CERBERUS were generally down-regulated during fracture healing. In contrast, Noggin was significantly up-regulated in the first week after fracture; 7 days after fracture, other BMP antagonists, including DAN, CHRD, Smad6 and BAMBI, also showed significantly increased expression. In conclusion, this study indicates that BMP antagonists can be divided into two functional groups in relation to fracture healing: (1) those whose suppression may be essential for the initiation of osteogenesis; (2) those that are upregulated and may function in the remodeling of newly formed bone.
Insights
Bone morphogenetic protein (BMP) antagonists are crucial for fracture healing. This study reveals two distinct roles for BMP antagonists in bone repair, impacting osteogenesis and bone remodeling.
Area of Science:
- Biochemistry
- Molecular Biology
- Orthopedics
Background:
- Bone morphogenetic proteins (BMPs) are key regulators of bone formation.
- BMP signaling is tightly controlled by BMP antagonists.
- Understanding BMP antagonist roles in fracture healing is essential for regenerative medicine.
Purpose of the Study:
- To investigate the dynamic expression patterns of BMPs and their antagonists during fracture healing.
- To elucidate the functional roles of BMP antagonists in the osteogenic process following bone fracture.
- To categorize BMP antagonists based on their involvement in distinct phases of fracture repair.
Main Methods:
- Controlled femur fracture model in 40 mice.
- Quantitative analysis of BMP and BMP antagonist gene expression at multiple time points post-fracture (days 1, 3, 7, 14, 21).
- Correlation of antagonist expression profiles with fracture healing stages.
Main Results:
- BMP-2, -4, and -7 were upregulated during fracture healing.
- BMP receptor expression (BMPR-1A, BMPR-2) decreased after day 14.
- Specific BMP antagonists (Noggin, DAN, CHRD, Smad6, BAMBI) were upregulated early, while others (PRDC, SOST, Smad7, GREM1, CERBERUS) were generally downregulated.
Conclusions:
- BMP antagonists can be functionally classified into two groups during fracture healing.
- Suppression of certain antagonists is critical for initiating osteogenesis.
- Upregulated antagonists likely play a role in the later stages of bone remodeling.
Related Concept Videos
01:31Bone Remodeling and Repair
01:27Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...